This re-emphasizes the predictive value of GALNT14-rs62139523 “A/G” genotype for favorable OS and PFS in intermediate-stage CRC patients receiving surgical resection followed by 5-FU-based adjuvant chemotherapy. This evidence concerns the gene GALNT14 and colorectal carcinoma.